随着手术技能的提高及新化学抗癌药物的问世,卵巢癌的近期疗效及5年存活率已有所提高。但因就诊时约70%～75%患者均为晚期(Ⅲ、Ⅳ期),经手术、化疗治疗后,仍有70%的晚期卵巢癌患者是带瘤生存,或在一定时期内复发(多数在2年内)。因此,对某些复发性卵巢癌可选用二次肿瘤细胞减灭 With the improvement of surgical skills and the advent of new chemical anti-cancer drugs, the recent curative effect and 5-year survival rate of ovarian cancer have been raised. However, about 70% -75% of the patients are in advanced stages (stages Ⅲ and Ⅳ). After operation and chemotherapy, 70% of patients with advanced ovarian cancer still have tumor-bearing survival or relapse within a certain period of time In 2 years). Therefore, some of the recurrence of ovarian cancer can choose secondary tumor cytoreductive